CYDY · CytoDyn Inc. · Exempt Offerings
$0.25
+0.00 (+0.04%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Oct 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company had an accumulated deficit of approximately $950.4 million as of August 31, 2026. These factors, among several others, raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed Oct 14, 2026
Market Cap
$367.38M
Shares
1.47B
Volume · Oct 20
7.35M
Avg daily vol (3M)
1.68M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-05-11 | New | Pharmaceuticals | $18,600,392 | $18,600,392 | 06b |
| 2022-09-19 | Amendment | Pharmaceuticals | $21,771,535 | $21,771,535 | 06c |
| 2022-04-25 | Amendment | Pharmaceuticals | Indefinite | $1,890,000 | 06c |
| 2022-04-22 | New | Pharmaceuticals | Indefinite | $1,890,000 | 06b |
| 2021-12-03 | New | Biotechnology | $53,593,700 | $11,361,000 | 06b |
| 2021-09-16 | New | Biotechnology | $25,220,000 | $2,872,000 | 06b |
| 2020-12-16 | New | Biotechnology | $1,176,000 | $0 | 06b |
| 2020-12-16 | New | Biotechnology | $1,000,000 | $1,000,000 | 06b |
| 2020-04-07 | Amendment | Biotechnology | $11,355,000 | $7,570,000 | 06b |
| 2020-03-30 | New | Biotechnology | $1,157,625 | $882,000 | 06b |
| 2020-02-14 | New | Biotechnology | $7,570,000 | $7,570,000 | 06b |
Showing 1–11 of 11 filings